Pramipexole Impurity 16
Pramipexole Impurity 16 物理性質
- 貯蔵温度 :
- -20°C
- 溶解性:
- H2O: >15mg/mL
- 外見 :
- 粉
- 色:
- 白からベージュ
- 光学活性 (optical activity):
- [α]/D 60 to 70°, c = 1 in methanol
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
| 主な危険性 |
Xi |
|
|
| Rフレーズ |
36/37/38 |
|
|
| Sフレーズ |
26 |
|
|
| WGK Germany |
3 |
|
|
| HSコード |
2934200000 |
|
|
| 絵表示（GHS） |
|
| 注意喚起語 |
警告 |
| 危険有害性情報 |
| コード |
危険有害性情報 |
危険有害性クラス |
区分 |
注意喚起語 |
シンボル |
P コード |
| H302 |
飲み込むと有害 |
急性毒性、経口 |
4 |
警告 |
|
P264, P270, P301+P312, P330, P501 |
|
| 注意書き |
|
Pramipexole Impurity 16 価格
もっと(7)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCP700745 |
(R)-Pramipexole Dihydrochloride |
104632-27-1 |
25mg |
￥85200 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCP700745 |
(R)-Pramipexole Dihydrochloride |
104632-27-1 |
10mg |
￥37400 |
2023-06-01 |
購入 |
|
Sigma-Aldrich Japan
|
1553815 |
United States Pharmacopeia (USP) Reference Standard
Pramipexole Related Compound D United States Pharmacopeia (USP) Reference Standard |
104632-27-1 |
25mg |
￥187000 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
PHR1824 |
Pharmaceutical Secondary Standard; Certified Reference Material
Pramipexole Related Compound D Pharmaceutical Secondary Standard; Certified Reference Material |
104632-27-1 |
50mg |
￥116000 |
2021-03-23 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCP700745 |
(R)-Pramipexole Dihydrochloride |
104632-27-1 |
50mg |
￥159600 |
2024-03-01 |
購入 |
Pramipexole Impurity 16 化学特性,用途語,生産方法
説明
Pramipexole (Item No.
11981) is an agonist of dopamine receptors that has applications in Parkinson’s disease and other disorders. Pramipexole is usually available as a mixture of enantiomers, with the majority of the dopamine receptor-dependent activity resulting from the (S) form. (R)-Pramipexole is an enantiomer of pramipexole that is ~100-fold less active than the (S) form as a dopamine receptor agonist. For this reason, it can be used as a negative control for the (S) form in the study of dopamine receptors. Both isoforms are antioxidants that target mitochondria to prevent apoptosis. This cytoprotective effect of (R)-pramipexole, without dopaminergic side effects, suggests utility in amyotrophic lateral sclerosis.
使用
(R)-Pramipexole Dihydrochloride (Pramipexole EP Impurity D; Pramipexole BP Impurity D; Pramipexole USP Related Compound D) is the opposite enantiomer of Pramipexole (P700755), a dopamine-D2-receptor agonist. Dexpramipexole is a low-molecular-weight, water-soluble, orally bioavailable, renally excreted compound with linear pharmacokinetics.
一般的な説明
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Pramipexole Related Compound D is a pharmaceutical impurity of pramipexole. Pramipexole is a non-ergot dopamine receptor agonist, widely used in the treatment of Parkinson′s disease.
Pramipexole Impurity 16 上流と下流の製品情報
原材料
準備製品
Pramipexole Impurity 16 生産企業
Global( 82)Suppliers
104632-27-1()キーワード:
アリピプラゾール
(S)-4,5,6,7-テトラヒドロ-N2,N6-プロピオニル-2,6-ベンゾチアゾールジアミン
デクスプラミペキソール
2-アミノ-6-ブロモ-5,6-ジヒドロ-7(4H)-ベンゾチアゾロン
ベンゾオキサゾール-2-アミン
(S)-(-)-2,6-ジアミノ-4,5,6,7-テトラヒドロベンゾチアゾール
プラミペキソール
2-アミノベンゾチアゾール
(S)-プラミペクソール二塩酸塩
N-(2-アミノ-4,5,6,7-テトラヒドロ-1,3-ベンゾチアゾール-6-イル)アセトアミド
N-(アミノチオキソメチル)-5-オキソ-1-プロピル-2-ピロリジンアセトアミド
2-アミノ-4,5,6,7-テトラヒドロ-6α-(プロピルアミノ)ベンゾチアゾール-7α-オール
- 104632-27-1
- 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, dihydrochloride, (R)-
- Kns 760704
- Snd 919cl2x
- DexpraMipexole (dihydrochloride)
- PraMipexole IMpurity D
- (R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride // (R)-Pramipexole dihydrochloride
- (R)-4,5,6,7-Tetrahydro-6-(propylamino)-benzothiazole-2-amine dihydrochloride
- RPPX
- Pramipexole Dihydrochloride Hydrate Impurity
- (R)-Pramipexole (hydrochloride)
- Pramipexole Dihydrochloride Hydrate IMP
- Pramipexole dihydrochloride impurity IV
- (R)-PRAMIPEXOLE DIHYDROCHLORIDE; KNS 760704; SND 919CL2X
- Pramipexole R-Isomer
- Pramipexole EP Impurity D DiHCl
- (6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine,dihydrochloride
- Dexpramipexole dihydrochloride
((R)-Pramipexole
- Pramipexole impurity D CRS
- KNS-760704 dihydrochloride
- (R)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine dihydrochloride
- Dexpramipexole HCl
- Pramipexole EP Impurity D ((R)-Pramipexole diHCl)
- Pramipexole Related Compound D ((R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydro (1553815)
- Dexpramipexole dihydrochloride ((R)-Pramipexole dihydrochloride
- Dopamine Receptor,inhibit,Inhibitor,KNS-760704,Dexpramipexole,Dexpramipexole dihydrochloride,(R)-Pramipexole,KNS760704,KNS 760704
- Pramipexole Impurity 4 Dihydrochloride（Pramipexole EP Impurity D Dihydrochloride）
- Glycerol Impurity 41((R)-3-chloropropane-1,2-diol)
- Dexpramipexole 2HCl
- Pramipexole BP Impurity D
- Pramipexole EP Impurity D HCl